SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shizuka Miura, Atsushi Suzuki, Acquisition of lipid metabolic capability in hepatocyte-like cells directly induced from mouse fibroblasts, Frontiers in Cell and Developmental Biology, 2014, 2,

    CrossRef

  2. You have free access to this content2
    Zhaohui Ye, Cyndi F. Liu, Lucie Lanikova, Sarah N. Dowey, Chaoxia He, Xiaosong Huang, Robert A. Brodsky, Jerry L. Spivak, Josef T. Prchal, Linzhao Cheng, Differential Sensitivity to JAK Inhibitory Drugs by Isogenic Human Erythroblasts and Hematopoietic Progenitors Generated from Patient-Specific Induced Pluripotent Stem Cells, STEM CELLS, 2014, 32, 1
  3. 3
    Zhenwei Song, Qianqian Ji, Haijing Zhao, Yu Nie, Zuyong He, Yaosheng Chen, Peiqing Cong, Generation of CD44 gene-deficient mouse derived induced pluripotent stem cells, In Vitro Cellular & Developmental Biology - Animal, 2014,

    CrossRef

  4. 4
    Hongmei Lisa Li, Takao Nakano, Akitsu Hotta, Genetic correction using engineered nucleases for gene therapy applications, Development, Growth & Differentiation, 2014, 56, 1
  5. 5
    Priyalakshmi Viswanathan, Terri Gaskell, Nathalie Moens, Oliver J. Culley, Darrick Hansen, Mia K. R. Gervasio, Yee J. Yeap, Davide Danovi, Human pluripotent stem cells on artificial microenvironments: a high content perspective, Frontiers in Pharmacology, 2014, 5,

    CrossRef

  6. 6
    Minghua Wang, Joong Sup Shim, Ruo-Jing Li, Yongjun Dang, Qingli He, Manisha Das, Jun O Liu, Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer, British Journal of Pharmacology, 2014, 171, 18
  7. 7
    S. Liebau, M. Stockmann, A. Illing, T. Seufferlein, A. Kleger, Induzierte pluripotente Stammzellen, Der Internist, 2014, 55, 4, 460

    CrossRef

  8. 8
    Jared L. Sterneckert, Peter Reinhardt, Hans R. Schöler, Investigating human disease using stem cell models, Nature Reviews Genetics, 2014, 15, 9, 625

    CrossRef

  9. 9
    Barbara Dupret, Pierre-Olivier Angrand, L’ingénierie des génomes par les TALEN, médecine/sciences, 2014, 30, 2, 186

    CrossRef

  10. 10
    Ning Sun, Huimin Zhao, Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs, Biotechnology and Bioengineering, 2014, 111, 5
  11. 11
    L. Ye, J. Wang, A. I. Beyer, F. Teque, T. J. Cradick, Z. Qi, J. C. Chang, G. Bao, M. O. Muench, J. Yu, J. A. Levy, Y. W. Kan, Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5 32 mutation confers resistance to HIV infection, Proceedings of the National Academy of Sciences, 2014, 111, 26, 9591

    CrossRef

  12. 12
    Ning Sun, Zehua Bao, Xiong Xiong, Huimin Zhao, SunnyTALEN: A second-generation TALEN system for human genome editing, Biotechnology and Bioengineering, 2014, 111, 4
  13. 13
    Stephen J. Haggarty, Roy H. Perlis, Translation: Screening for Novel Therapeutics With Disease-Relevant Cell Types Derived from Human Stem Cell Models, Biological Psychiatry, 2014, 75, 12, 952

    CrossRef

  14. 14
    Chuanxian Wei, Jiyong Liu, Zhongsheng Yu, Bo Zhang, Guanjun Gao, Renjie Jiao, TALEN or Cas9 – Rapid, Efficient and Specific Choices for Genome Modifications, Journal of Genetics and Genomics, 2013, 40, 6, 281

    CrossRef